Yn dangos 1051 i 1065 o 2099 canlyniadau
Joint statement on meeting regulatory standards during periods of global or national shortage of medicines
We are concerned to hear that people with Type 2 diabetes are experiencing problems accessing GLP-1 receptor agonists (GLP-1 RAs).
Tell us what you think about the Partner Portal with our short survey
Have your say on our Partner Portal. Has it helped you? What could we do differently? Your feedback will help us improve